Venturi Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 3,001 shares of the pharmacy operator’s stock, valued at approximately $28,000.
Several other institutional investors have also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. boosted its stake in Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Altrius Capital Management Inc raised its holdings in shares of Walgreens Boots Alliance by 76.6% in the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after buying an additional 190,996 shares during the last quarter. Swedbank AB lifted its position in Walgreens Boots Alliance by 45.3% during the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after buying an additional 185,762 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in Walgreens Boots Alliance by 23.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after acquiring an additional 64,586 shares during the last quarter. Finally, Sasco Capital Inc. CT increased its position in Walgreens Boots Alliance by 13.6% in the 3rd quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock valued at $9,331,000 after acquiring an additional 124,950 shares in the last quarter. 58.59% of the stock is owned by institutional investors.
Analysts Set New Price Targets
WBA has been the topic of a number of research reports. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Evercore ISI lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday. Finally, Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $12.63.
Walgreens Boots Alliance Stock Down 3.0 %
Shares of NASDAQ WBA opened at $11.04 on Thursday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a market cap of $9.54 billion, a P/E ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.64. The firm has a 50 day moving average price of $10.44 and a 200 day moving average price of $9.71.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.66 EPS. Analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- Transportation Stocks Investing
- Buffett’s on the Sidelines – Should You Follow?
- Stock Dividend Cuts Happen Are You Ready?
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.